Skip to main content About News Giving All Departments Contact Us Site Map
 University of Texas Southwestern Medical School
 
Search       
Print Friendly  
spacer Home Education Research Patient Care Faculty & Administration Resource Careers
Faculty Directory Administration Administrative Departments
border=0
| Home > Faculty & Administration >
David Boothman

 
 
Faculty Directory
 
 
Find a Doctor
 
 
Faculty Research Interests
 
 
Search Help
 
 
Update Faculty ProfileAccessible on campus or vpn
 
 
 

David Boothman, Ph.D.

 Personal Overview

Biographical Sketch Details of Research Personal Overview How to Contact
David Boothman
Name:
  David Allen Boothman, Ph.D.
Endowed Title:
  Robert B. and Virginia Payne Professorship in Oncology
Academic Title:
  Professor
Primary Appointment:
  Simmons Comprehensive Cancer Center
Secondary Appointment:
  Pharmacology
School:
  Graduate School of Biomedical Sciences
Southwestern Medical School
Degree Program:
  Cell Regulation
Genetics and Development
Pharmacological Science
Non-degree Program:
  Physician Scientist Training Program
SURF
Affiliations:
  Hamon Center for Therapeutic Oncology
Komen Alliance Breast Cancer Research
Moncrief Radiation Oncology Center
Radiation Oncology
Simmons Comprehensive Cancer Center
Department Website:
  Simmons Comprehensive Cancer Center
Lab Website:
  Boothman Lab Website
Email:
  David Boothman, Ph.D.

 PERSONAL OVERVIEW
     
Boothman, David A.
Professor, Associate Director for Translational Research

University of Michigan B.S. 1981 Microbiology
University of Miami Ph.D. 1986 Microbiology & Immunology

1986-1989 Postdoctoral Fellow, Mol. Pharm. & Cell Growth and Reg., Harvard Medical School, Dana-Farber Cancer Inst.
1989-1993 Assistant Professor, Dept. Radiation Oncology, Div. Cancer Biology, U Michigan
1993-1996 Assistant Professor, Dept. of Human Oncology, U W-Madison
1996-1998 Associate Professor, Vice Chairman of Basic Research, Human Oncology, U W-Madison
1998-2001 Associate Professor, Radiation Oncology, Pharmacology, CWRU
2001-2005 Professor, Radiation Oncology, Pharmacol. CWRU
2002-2005 Associate Dir Basic Research, Distinguished Inv. Award, CWRU
2005-present Robert and Virginia Payne Professor of Oncology, UTSW
2005-present Co-Director, ?Program in Cell Stress and Cancer Nanomedicine?, UTSW
2005-present Associate Dir. Translational Research, UTSW

1993-1999 NIH, Radiation Biol., Chem. Path B Study Section
1997-2002 NIH ET-2 Study Section
2002-2005 DT Study Section
1997-Present DOD Prostate and Breast Cancer
1997-Present DOE/NASA Low Dose IR Effects
1999-Present NIH Program Project/SPORE Grants
2005-Present NIH Traineeship Awards
2007-Present RTB Study Section

Honors
1985 AACR-Upjohn Travel Award
1985 Dir., Eastern Student Research Forum (AMA)
1988 NRSA Tumor Biology Fellowship
1993-2005 Distinguished Investigator Award, CWRU
2005-Pres Robert B. and Virginia Payne Professor of Oncology

B. Recent peer-reviewed pubs (from >100):
Shannan, B, Seifert, M, Boothman, DA, Tilgen, W, and Reichrath, J. Clusterin over-expression modulates proapoptotic and antiproliferative effects of 1,25(OH)(2)D(3) in prostate cancer cells in vitro. J. Ster Biochem Mol Biol. 2007; 103: 721-725.

Bey EA, Bentle MS, Reinicke KE, Dong Y, Yang CR, Girard L, Minna JD, Bornmann WG, Gao J, Boothman DA. An NQO1-and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone. PNAS 2007; 104: 11832-7.

Choi, EK, Terai, K, Ji, I-M, Kook, Y, Park, K, Oh, E, Griffin, R, Lim, B, Lee, D, Boothman, DA, Loren, M, Song, CW, and Park, HJ. Radiation-induced up-regulation of NAD(P)H:quinone oxidoreductase (NQO1) potentiates the effect of bioreductive ?-lapachone against cancer cells. Neoplasia 2007; 9(8): 634-642.

Bentle MS, Reinicke KE, Dong Y, Bey EA, Boothman DA. Non-homologous end joining is essential for cellular resistance to beta-lapachone. Cancer Res. 2007; 67(14): 6936-45.

Blanco E, Bey EA, Dong Y, Weinberg BD, Sutton DS, Boothman DA, Gao J. Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells. J Con Rel 2007; 122(3): 365-74. Epub 2007 Apr 29.

Gomez J, Gama V, Yoshida T, Sun W, Hayes P, Leskov K, Boothman DA, Matsuyama S. Bax-inhiiting peptides derived from Ku70 and cell-penetrating pentapeptides. Biochem. Soc. Trans. 2007; 53: 797-801.

Wagner, MW, Li, LS, Morales, JC, Galindo, CL, Garner, HR, Bornmann, WG, and Boothman, DA. Role of c-Abl in MMR-dependent G2 arrest responses. JBC 2008; 283: 21382-21393.

Li, LS, Morales, JC, Hwang, A, Wagner, MW, and Boothman, DA. DNA mismatch repair-dependent activation of c-Abl/p73a/GADD45a-mediated apoptosis. JBC 2008; 283: 21394-21403.

Suzuki, M and Boothman, DA Modulating stress-induced premature senescence (SIPS) for therapy. J. Rad Res., 2008; 49: 105-112.
 
 INTERESTING LINKS
 
   Department Website: Simmons Comprehensive Cancer Center
   Lab Website: Boothman Lab Website
   Other Website: Boothman Laboratory Website